China FDA issues 'user-friendly' guidance on medical device registration studies; waivers may prove a challenge

The China Food and Drug Administration has for the first time issued guidance that explains how medical device makers should conduct clinical evaluations of the products they seek to register in China and in which cases they may obtain a clinical study waiver1.